The Role of Oxidative Stress in Trisomy 21 Phenotype

Cell Mol Neurobiol. 2023 Nov;43(8):3943-3963. doi: 10.1007/s10571-023-01417-6. Epub 2023 Oct 11.

Abstract

Extensive research has been conducted to gain a deeper understanding of the deregulated metabolic pathways in the development of trisomy 21 (T21) or Down syndrome. This research has shed light on the hypothesis that oxidative stress plays a significant role in the manifestation of the T21 phenotype. Although in vivo studies have shown promising results in mitigating the detrimental effects of oxidative stress, there is currently a lack of introduced antioxidant treatment options targeting cognitive impairments associated with T21. To address this gap, a comprehensive literature review was conducted to provide an updated overview of the involvement of oxidative stress in T21. The review aimed to summarize the insights into the pathogenesis of the Down syndrome phenotype and present the findings of recent innovative research that focuses on improving cognitive function in T21 through various antioxidant interventions. By examining the existing literature, this research seeks to provide a holistic understanding of the role oxidative stress plays in the development of T21 and to explore novel approaches that target multiple aspects of antioxidant intervention to improve cognitive function in individuals with Down syndrome. The guides -base systematic review process (Hutton et al. 2015).

Keywords: Antioxidant capacity; Cognitive impairment; Lipid peroxidation; Mitochondrial dysfunction; Oxidative stress; Trisomy 21.

Publication types

  • Review

MeSH terms

  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Cognition
  • Down Syndrome* / genetics
  • Humans
  • Oxidative Stress
  • Phenotype

Substances

  • Antioxidants